Nova Patents
HRP20031069A2

Azaindoles

Abstract

The invention is directed to compounds of general formula (I):- and pharmaceutically acceptable salts and solvates of such compounds. Such compounds have valuable pharmaceutical properties, in particular the ability to inhibit kinases.

Term

Term ended

Projected expiry passed 20 June 2022, 4.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

48 members in 32 offices

This recordMember, by publication datePriority claim22 more offices are in the list below

Priority claims11

Priority claims
DocumentOfficeKindDate
0115109United KingdomA
0115109United KingdomA
30025701United States of AmericaP
30025701United States of AmericaP
0202799United KingdomW
0202799United KingdomW
01151091
GB20010015109
PCTGB0202799
US20010300257P
WO2002GB02799

Members48

Family members, oldest first
DocumentOfficeKind
CA2451678A1CanadaA1
WO03000688A1World Intellectual Property Organization (WIPO)A1
UY27350A1UruguayA1
NO20035476D0NorwayD0
AP2003002940A0African Regional Intellectual Property Organization (ARIPO)A0
NO20101256LNorwayL
KR20040018284ARepublic of KoreaA
CZ20033444A3CzechiaA3
EP1397360A1European Patent Office (EPO)A1
US2004053931A1United States of AmericaA1
EE200400015AEstoniaA
HRP20031069A2This recordCroatiaA2
IL159445A0IsraelA0
SK15902003A3SlovakiaA3
BR0210507ABrazilA
AR036106A1ArgentinaA1
SI21462ASloveniaA
JP2004534826AJapanA
MA27043A1MoroccoA1
PL365067A1PolandA1
HU0400247A2HungaryA2
HUP0400247A2HungaryA2
RU2004101408ARussian FederationA
US6897207B2United States of AmericaB2
ZA200309648BSouth AfricaB
BG108481ABulgariaA
CO5540345A2ColombiaA2
CN1665809AChinaA
US2005267304A1United States of AmericaA1
TNSN03110A1TunisiaA1
NZ529205ANew ZealandA
OA12637AAfrican Intellectual Property Organization (OAPI)A
AP1739AAfrican Regional Intellectual Property Organization (ARIPO)A
NZ545741ANew ZealandA
RU2326880C2Russian FederationC2
MY137099AMalaysiaA
AU2009200024A1AustraliaA1
UA85660C2UkraineC2
KR20090035650ARepublic of KoreaA
CN100509811CChinaC
RU2008101827ARussian FederationA
KR100915289B1Republic of KoreaB1
JP4409938B2JapanB2
KR100977344B1Republic of KoreaB1
EP2233486A1European Patent Office (EPO)A1
TWI334417BTaiwan Province of ChinaB
CA2451678CCanadaC
US7943616B2United States of AmericaB2